Abstract: The present disclosure relates to the reduction of methane production in ruminants. In particular, the disclosure relates to solid and semi-solid compositions for administration to a ruminant comprising a substance capable of inhibiting the production of methane in vivo in the ruminant. The disclosure also relates to controlled release boluses, animal licks, and animal feeds comprising solid and semi-solid compositions comprising a substance capable of inhibiting the production of methane in vivo in a ruminant. The disclosure further relates to methods of orally administering boluses capable of inhibiting the production of methane in vivo in a ruminant to ruminants and methods of orally transferring substances capable of inhibiting the production of methane in vivo in a ruminant to ruminants. In addition, the disclosure relates to viruses capable of inhibiting archaea that produce methane in vivo in a ruminant.

Abstract: The present disclosure relates to the reduction of methane production in ruminants. In particular, the disclosure relates to solid and semi-solid compositions for administration to a ruminant comprising a substance capable of inhibiting the production of methane in vivo in the ruminant. The disclosure also relates to controlled release boluses, animal licks, and animal feeds comprising solid and semi-solid compositions comprising a substance capable of inhibiting the production of methane in vivo in a ruminant. The disclosure further relates to methods of orally administering boluses capable of inhibiting the production of methane in vivo in a ruminant to ruminants and methods of orally transferring substances capable of inhibiting the production of methane in vivo in a ruminant to ruminants. In addition, the disclosure relates to viruses capable of inhibiting archaea that produce methane in vivo in a ruminant.

Abstract: The present disclosure relates to compositions and kits for the treatment or prevention of a bacterial disease in a terrestrial plant or animal, comprising a phage and/or an immunogenic agent and a flying insect attractant. The disclosure also relates to methods for attracting flying insects to phages and/or immunogenic agents. The disclosure also relates to the use of a flying insect in a method of transferring a phage and/or immunogenic agent to an animal or plant, and to methods of treating or preventing disease in animals and plants using flying insects. The disclosure also relates to formulations of phages and/or immunogenic agents for use in treating and/or preventing disease in animals or plants.

Abstract: The invention relates to a method and device for neuromuscular stimulation of one or more muscles, or muscle groups, with one or more beneficial effects selected from increasing arterial, venous and capillary blood flow, increasing flux of interstitial fluid and lymphatic drainage, increasing tissue oxygenation, enhancing heat distribution, enhancing the distribution of pharmaceutical products, and enhancing performance and recovery from exertion in horses.

Abstract: The invention relates to a method and device for neuromuscular stimulation of one or more muscles, or muscle groups, with one or more beneficial effects selected from increasing arterial, venous and capillary blood flow, increasing flux of interstitial fluid and lymphatic drainage, increasing tissue oxygenation, enhancing heat distribution, enhancing the distribution of pharmaceutical products, and enhancing performance and recovery from exertion in horses.